Reference drugs for triple combination test drug in Russia [Design Issues]

posted by PharmCat  – Russia, 2019-11-13 21:25 (385 d 10:11 ago) – Posting: # 20801
Views: 3,329

» i.e. 2 tablets. All of these drugs are reference drugs according to the GRLS system.
» What is your opinion which option to choose?


Strictly for bioequivalence you should chose drug from register that have label "Reference drug". If no such drug - you should make
efficacy trial.

I heard there was a case when drug was registered in EU and BE in Russia was performed with separate reference drugs - but now this case is not approvable, but some companies try to do this.

If say strict - both cases is wrong.

Complete thread:

 Admin contact
21,232 posts in 4,427 threads, 1,482 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Thursday 07:37 CET (Europe/Vienna)

Every man is fully satisfied that there is such a thing as truth,
or he would not ask any question.    Charles Sanders Peirce

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz